Apixaban and Lepirudin: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Aug 8, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Apixaban
Lepirudin
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines are blood thinners. Apixaban (Eliquis) blocks a clotting protein called factor Xa, and lepirudin blocks clotting a different way. When you take them together, their effects add up, so your blood becomes even less able to clot. That means a higher chance of serious bleeding.
Watch for warning signs like unusual bruising, pink or red urine, black or bloody stools, nosebleeds that will not stop, coughing or vomiting blood, or a bad headache. If any of these happen, get medical help or go to the emergency room right away. The good news is that your care team can manage this carefully, and there are treatments to reverse apixaban if a bleed occurs.
Additive anticoagulation. Apixaban (a direct factor Xa inhibitor) plus lepirudin (a direct thrombin inhibitor) produces overlapping anticoagulant effects and a clinically significant increase in bleeding risk. Neither is a prodrug; this is a pharmacodynamic, not metabolic, interaction. PD studies show apixaban with enoxaparin raised anti-FXa activity by 50 to 60 percent, illustrating the additive potential.
- Severity: major; evidence: probable.
- Effect persistence: apixaban PD effect lasts at least 24 hours after the last dose.
- Management: avoid overlap unless clearly indicated; discontinue apixaban if active pathological bleeding occurs. Reversal agent (andexanet alfa) available; PCC, aPCC, or rFVIIa may be considered. With PCC, PT/INR/aPTT or anti-FXa monitoring is not useful.
What happens
An increased risk of bleeding and can cause serious, potentially fatal bleeding
Interaction Deep Dive
Giving apixaban, a factor Xa inhibitor, together with another anticoagulant raises the likelihood of bleeding. Pharmacodynamic interaction studies involving apixaban showed that anti-factor Xa activity rose by 50% to 60% when apixaban was administered alongside enoxaparin. If active pathological bleeding develops, apixaban should be stopped. There is an agent available that reverses apixaban's anti-factor Xa activity. Apixaban's pharmacodynamic effect is anticipated to remain for a minimum of 24 hours following the final dose. Patients should be counseled on the signs and symptoms of blood loss and instructed to report them without delay or present to an emergency room. Prothrombin complex concentrate (PCC), activated prothrombin complex concentrate, or recombinant factor VIIa may be considered. If PCCs are administered, using a clotting test (PT, INR, or aPTT) or anti-factor Xa (FXa) activity to monitor the anticoagulant effect of apixaban is not helpful and is not recommended. Activated oral charcoal decreases apixaban absorption, which in turn reduces apixaban exposure1.
Why it happens (mechanism)
Additive anticoagulation
How to manage this interaction
Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise. Do not start or stop either one on your own. Because both thin the blood, your care team will weigh whether you truly need both at once, and if so, they will monitor you more closely.
- Learn the signs of bleeding: unusual bruising, red or black stools, pink or red urine, prolonged nosebleeds, coughing or vomiting blood, or a severe headache.
- Report any of these immediately or go to the emergency room.
- Remember apixaban's effect can last at least 24 hours after your last dose.
- Ask your pharmacist or doctor any questions about your specific plan.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) In investigations of pharmacodynamic drug interactions involving apixaban, an increase of 50% to 60% in anti-factor Xa activity was seen when apixaban and enoxaparin were given together 1.
Common questions
Can I take Apixaban and Lepirudin together?
Taking apixaban and lepirudin together adds two blood thinners on top of each other and raises the risk of serious bleeding, so use them together only under close medical supervision and get help right away for any bleeding signs. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Apixaban and Lepirudin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Apixaban and Lepirudin interaction managed?
Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise. Do not start or stop either one on your own. Because both thin the blood, your care team will weigh whether you truly need both at once, and if so, they will monitor you more closely. Learn the signs of bleeding: unusual bruising, red or black stools, pink or red urine, prolonged nosebleeds, coughing or vo… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Apixaban or Lepirudin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: ELIQUIS(R) oral film coated tablets, apixaban oral film coated tablets. Bristol-Myers Squibb Company (per Dailymed), Princeton, NJ, 2024. DailyMed
Keep reading about Apixaban
Keep reading about Lepirudin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist